This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francis, C.
Right arrow Articles by et, al.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Francis, C.
Right arrow Articles by et, al.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 71, Issue 3 327-335, Copyright © 1989 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40

CW Francis, VD Pellegrini, VJ Marder, CM Harris, S Totterman, KR Gabriel, DJ Baughman, S Roemer, J Burke, TL Goodman and al. et
University of Rochester School of Medicine and Dentistry, New York 14642.

The anticoagulant action of heparin is mediated through antithrombin III, and the postoperative decrease in the plasma concentration of antithrombin III may contribute to the relative ineffectiveness of prophylaxis with low-dose heparin in preventing venous thrombosis after total hip arthroplasty. We conducted a prospective, randomized trial to compare the effectiveness of a regimen of antithrombin III, given intravenously once daily, and low-dose heparin with a regimen of dextran 40, given intravenously, in preventing venographically documented venous thrombosis after total hip arthroplasty. The results demonstrated an incidence of venous thrombosis of 4.9 per cent in patients who received antithrombin III and heparin; this was significantly lower than the incidence (28.6 per cent) in patients who received dextran 40 (p less than 0.005). Venous thrombosis occurred only in patients who had total hip arthroplasty with a cemented prosthesis (fourteen of fifty-seven patients, or 24.6 per cent); none of the twenty-six patients in whom a non-cemented prosthesis was used had venous thrombosis (p less than 0.01). Of the patients in whom a cemented prosthesis had been inserted, the incidence of venous thrombosis was lower in those who were treated with antithrombin III and heparin (7.4 per cent) than in those who were treated with dextran 40 (40 per cent) (p less than 0.005). Postoperative levels of antithrombin III were maintained at more than 90 per cent of the baseline level in patients who received it; this was significantly higher than in patients who received dextran 40.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
W. J. CICCONE, P. S. FOX, M. NEUMYER, D. RUBENS, W. M. PARRISH, and V. D. PELLEGRINI
Ultrasound Surveillance for Asymptomatic Deep Venous Thrombosis after Total Joint Replacement
J. Bone Joint Surg. Am., August 1, 1998; 80(8): 1167 - 74.
[Abstract] [Full Text]


Home page
JBJSHome page
C. W. FRANCIS, V. D. PELLEGRINI JR., S. TOTTERMAN, A. D. BOYD JR., V. J. MARDER, K. M. LIEBERT, B. N. STULBERG, D. C. AYERS, A. ROSENBERG, C. KESSLER, et al.
Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin and Dalteparin
J. Bone Joint Surg. Am., September 1, 1997; 79(9): 1365 - 72.
[Abstract] [Full Text]


Home page
JBJSHome page
D. C. AYERS, D. A. DENNIS, N. A. JOHANSON, and V. D. PELLEGRINI JR.
Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Common Complications of Total Knee Arthroplasty*{{dagger}}
J. Bone Joint Surg. Am., February 1, 1997; 79(2): 278 - 311.
[Full Text]